• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Comprehensive Overview of 4-(4-Bromophenyl)-1-methylpyrazol-5-amine (CAS No. 1248796-80-6): Properties, Applications, and Industry Insights

4-(4-Bromophenyl)-1-methylpyrazol-5-amine (CAS No. 1248796-80-6) is a specialized organic compound gaining traction in pharmaceutical and agrochemical research. This brominated pyrazole derivative features a unique molecular structure combining a 4-bromophenyl group with a methyl-substituted pyrazole amine, making it valuable for targeted synthesis. Recent PubMed studies highlight its potential as a kinase inhibitor scaffold, aligning with growing interest in precision medicine approaches.

The compound's structure-activity relationship (SAR) has attracted attention in drug discovery circles, particularly for designing selective enzyme modulators. Its molecular weight of 251.12 g/mol and balanced lipophilicity (LogP ≈ 2.8) make it suitable for blood-brain barrier penetration studies. Analytical characterization typically involves HPLC purity analysis (>98%) and LC-MS confirmation, with the bromine atom providing distinct mass spectral signatures.

In material science applications, researchers are exploring 4-(4-Bromophenyl)-1-methylpyrazol-5-amine as a building block for organic electronic materials. The bromine moiety enables cross-coupling reactions like Suzuki-Miyaura transformations, facilitating the creation of conjugated systems for OLED development. This aligns with the global push toward sustainable optoelectronics, a trending topic in Green Chemistry forums.

Safety assessments indicate the compound requires standard laboratory handling precautions (gloves, eye protection). While not classified as hazardous under GHS criteria, proper chemical storage protocols in amber glass at -20°C are recommended for long-term stability. The amine functionality suggests potential solubility in polar organic solvents (DMSO, ethanol), though comprehensive solubility profile data remains an active research area.

Patent analysis reveals increasing references to CAS 1248796-80-6 in heterocyclic chemistry innovations, particularly for crop protection agents and veterinary pharmaceuticals. The agrochemical sector values its potential as a metabolically stable bioactive core, with several patent applications pending for novel fungicidal compositions. These developments correspond with rising Google searches for "next-generation agrochemical intermediates" and "pyrazole-based bioactive compounds".

Synthetic routes to 4-(4-Bromophenyl)-1-methylpyrazol-5-amine typically involve multi-step organic synthesis starting from 4-bromobenzaldehyde derivatives. Recent process chemistry optimization publications describe improved yields (up to 76%) via microwave-assisted cyclization techniques. Such methodological advances address the growing demand for green synthesis protocols, a hot topic in ACS Green Chemistry discussions.

The compound's crystallographic data (when available) provides valuable insights for computational chemistry modeling studies. Density functional theory (DFT) calculations suggest interesting electronic distribution patterns that may explain its observed biological activity profiles. These computational approaches complement experimental research, as evidenced by increasing citations in Journal of Medicinal Chemistry articles.

Quality control specifications for CAS 1248796-80-6 typically require NMR spectroscopic validation (1H, 13C) and residual solvent analysis by GC. The pharmaceutical-grade material commands premium pricing in specialty chemical markets, reflecting its value in high-throughput screening libraries. Market analysts note growing procurement inquiries from contract research organizations (CROs) servicing the drug discovery sector.

Environmental fate studies of related brominated aromatic compounds suggest moderate persistence with biodegradation half-lives of 30-60 days in aerobic conditions. However, specific ecotoxicological data for this particular derivative remains limited, representing a knowledge gap frequently queried in REACH compliance discussions. This aligns with increasing regulatory focus on chemical sustainability metrics across industries.

Future research directions likely include exploring structure-property relationships through systematic derivatization studies, particularly focusing on the amine group reactivity. The compound's versatility positions it as a promising candidate for fragment-based drug design approaches, currently a trending topic in medicinal chemistry conferences. Such applications capitalize on the scaffold's balanced molecular complexity and vectorial diversity for lead optimization.

• 30823-51-9(1-methyl-4-phenyl-1H-pyrazol-3-amine)
• 57999-08-3(4-(4-Bromophenyl)-2H-pyrazol-3-amine)
• 40545-64-0(4-(4-bromophenyl)-1h-pyrazol-3-amine)
• 1003992-26-4(4-(4-Bromophenyl)-1-phenyl-1H-pyrazol-5-amine)
• 93115-68-5(1-methyl-4-phenyl-1H-pyrazol-3-amine hydrochloride)
• 1782569-25-8(3-Amino-4-(4-bromophenyl)-1-methylpyrazole)
• 30823-52-0(1-Methyl-4-phenyl-1H-pyrazol-5-amine)
• 1013837-41-6(4-(4-BROMOPHENYL)-1-TOSYL-1H-PYRAZOL-5-AMINE)
• 1152678-01-7(4-(4-Bromophenyl)-2,5-dimethylpyrazol-3-amine)
• 1156165-95-5(4-(3-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine)